3rd Peptides Conference

A session at 3rd Peptides Conference

The global peptide therapeutics market is expected to reach a value of US$23.7B by 2020 as a result of their efficacy for treating a huge array of conditions including cancer, metabolic disorders, nervous system disorders and gastrointestinal disorders among others. As such, further research has been done to develop a rich pipeline of novel peptides.

SMi’s CPD-certified conference provides the perfect platform to discuss the latest innovations in the peptides industry and explore a number of pressing issues such as the use of Cell Penetrating Peptides (CPP), the challenges involved with oral peptides and novel technologies for development and improvement.

Plus 2 interactive pre-conference workshops:
A: Cyclic Peptides - Discovery, Development and Deployment
B: Cupid Cell-Penetrating Peptides - a powerful new tool for cellular research

Early Bird Discounts:
Book by 31st March and save £500.
Book by 29th April and save £300.
Book by 27th May and save £200.

Booking: http://atnd.it/50529-1
Inquiries: http://atnd.it/50529-2
Tickets: http://atnd.it/50529-3

Book by 31 March: GBP 999
Book by 29 April: GBP 1199
Book by 27 May: GBP 1299
Standard Conference Only: GBP 1499
Standard Conference + 2 workshops: GBP 2697
Standard Conference + 1 Workshop: GBP 2098
2 Workshops only: GBP 1198
1 Workshop only: GBP 599

Speakers: MedImmune, Sanofi-Aventis, Ipsen, Ministry of Foreign Affairs Denmark, Bicycle Therapeutics, Proxima Concepts

Sign in to add slides, notes or videos to this session

Tell your friends!


Date Wed 6th July 2016

Short URL


Official event site


View the schedule


See something wrong?

Report an issue with this session